Back to results
US 2025/0082644 A1Published application
Combination therapies for the treatment of cancer
AssigneeCuris, Inc.
InventorsReinhard von Roemeling, Andrey Ugolkov, Robert Martell
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating certain diseases and disorders (e.g., cancer) with a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog.
Claims21
1-208. (canceled)
A method of treating cancer in a subject, comprising conjointly administering to the subject a nucleoside analog, venetoclax, and
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.